<code id='8C53F65CE0'></code><style id='8C53F65CE0'></style>
    • <acronym id='8C53F65CE0'></acronym>
      <center id='8C53F65CE0'><center id='8C53F65CE0'><tfoot id='8C53F65CE0'></tfoot></center><abbr id='8C53F65CE0'><dir id='8C53F65CE0'><tfoot id='8C53F65CE0'></tfoot><noframes id='8C53F65CE0'>

    • <optgroup id='8C53F65CE0'><strike id='8C53F65CE0'><sup id='8C53F65CE0'></sup></strike><code id='8C53F65CE0'></code></optgroup>
        1. <b id='8C53F65CE0'><label id='8C53F65CE0'><select id='8C53F65CE0'><dt id='8C53F65CE0'><span id='8C53F65CE0'></span></dt></select></label></b><u id='8C53F65CE0'></u>
          <i id='8C53F65CE0'><strike id='8C53F65CE0'><tt id='8C53F65CE0'><pre id='8C53F65CE0'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:Wikipedia    Page View:469
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In